Annual EBITDA
-$73.23 M
-$20.27 M-38.28%
December 31, 2023
Summary
- As of February 7, 2025, CABA annual EBITDA is -$73.23 million, with the most recent change of -$20.27 million (-38.28%) on December 31, 2023.
- During the last 3 years, CABA annual EBITDA has fallen by -$39.76 million (-118.75%).
- CABA annual EBITDA is now -1082.53% below its all-time high of -$6.19 million, reached on December 31, 2018.
Performance
CABA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$32.62 M
-$2.77 M-9.28%
September 30, 2024
Summary
- As of February 7, 2025, CABA quarterly EBITDA is -$32.62 million, with the most recent change of -$2.77 million (-9.28%) on September 30, 2024.
- Over the past year, CABA quarterly EBITDA has dropped by -$4.98 million (-18.03%).
- CABA quarterly EBITDA is now -1479.76% below its all-time high of -$2.06 million, reached on December 31, 2018.
Performance
CABA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$112.92 M
-$14.31 M-14.51%
September 30, 2024
Summary
- As of February 7, 2025, CABA TTM EBITDA is -$112.92 million, with the most recent change of -$14.31 million (-14.51%) on September 30, 2024.
- Over the past year, CABA TTM EBITDA has dropped by -$28.64 million (-33.98%).
- CABA TTM EBITDA is now -3566.33% below its all-time high of -$3.08 million, reached on September 30, 2018.
Performance
CABA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CABA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.3% | -18.0% | -34.0% |
| 3 y3 years | -118.8% | -187.6% | -174.5% |
| 5 y5 years | -1082.5% | -552.6% | -507.8% |
CABA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.7% | at low | -185.8% | at low | -147.8% | at low |
| 5 y | 5-year | -294.2% | at low | -461.6% | at low | -507.8% | at low |
| alltime | all time | -1082.5% | at low | -1479.8% | at low | -3566.3% | at low |
Cabaletta Bio EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.62 M(+9.3%) | -$112.92 M(+14.5%) |
| Jun 2024 | - | -$29.85 M(+8.0%) | -$98.61 M(+17.0%) |
| Mar 2024 | - | -$27.64 M(+21.2%) | -$84.28 M(+15.1%) |
| Dec 2023 | -$73.23 M(+38.3%) | -$22.81 M(+24.6%) | -$73.23 M(+10.3%) |
| Sep 2023 | - | -$18.31 M(+18.0%) | -$66.37 M(+11.6%) |
| Jun 2023 | - | -$15.52 M(-6.5%) | -$59.47 M(+4.8%) |
| Mar 2023 | - | -$16.59 M(+4.1%) | -$56.77 M(+7.2%) |
| Dec 2022 | -$52.96 M(+16.2%) | -$15.94 M(+39.7%) | -$52.96 M(+4.5%) |
| Sep 2022 | - | -$11.41 M(-11.0%) | -$50.68 M(+0.1%) |
| Jun 2022 | - | -$12.82 M(+0.3%) | -$50.60 M(+3.8%) |
| Mar 2022 | - | -$12.78 M(-6.4%) | -$48.76 M(+7.0%) |
| Dec 2021 | -$45.58 M | -$13.66 M(+20.4%) | -$45.58 M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$11.34 M(+3.3%) | -$41.14 M(+7.9%) |
| Jun 2021 | - | -$10.98 M(+14.5%) | -$38.13 M(+8.1%) |
| Mar 2021 | - | -$9.60 M(+4.1%) | -$35.26 M(+5.3%) |
| Dec 2020 | -$33.48 M(+80.2%) | -$9.22 M(+10.7%) | -$33.48 M(+11.3%) |
| Sep 2020 | - | -$8.33 M(+2.6%) | -$30.07 M(+12.4%) |
| Jun 2020 | - | -$8.11 M(+3.8%) | -$26.74 M(+19.3%) |
| Mar 2020 | - | -$7.82 M(+34.6%) | -$22.41 M(+20.6%) |
| Dec 2019 | -$18.58 M(+200.0%) | -$5.81 M(+16.2%) | -$18.58 M(+25.2%) |
| Sep 2019 | - | -$5.00 M(+32.2%) | -$14.84 M(+14.9%) |
| Jun 2019 | - | -$3.78 M(-5.2%) | -$12.92 M(+41.4%) |
| Mar 2019 | - | -$3.99 M(+93.2%) | -$9.13 M(+77.6%) |
| Dec 2018 | -$6.19 M | -$2.06 M(-33.0%) | -$5.14 M(+67.0%) |
| Sep 2018 | - | -$3.08 M | -$3.08 M |
FAQ
- What is Cabaletta Bio annual EBITDA?
- What is the all time high annual EBITDA for Cabaletta Bio?
- What is Cabaletta Bio annual EBITDA year-on-year change?
- What is Cabaletta Bio quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cabaletta Bio?
- What is Cabaletta Bio quarterly EBITDA year-on-year change?
- What is Cabaletta Bio TTM EBITDA?
- What is the all time high TTM EBITDA for Cabaletta Bio?
- What is Cabaletta Bio TTM EBITDA year-on-year change?
What is Cabaletta Bio annual EBITDA?
The current annual EBITDA of CABA is -$73.23 M
What is the all time high annual EBITDA for Cabaletta Bio?
Cabaletta Bio all-time high annual EBITDA is -$6.19 M
What is Cabaletta Bio annual EBITDA year-on-year change?
Over the past year, CABA annual EBITDA has changed by -$20.27 M (-38.28%)
What is Cabaletta Bio quarterly EBITDA?
The current quarterly EBITDA of CABA is -$32.62 M
What is the all time high quarterly EBITDA for Cabaletta Bio?
Cabaletta Bio all-time high quarterly EBITDA is -$2.06 M
What is Cabaletta Bio quarterly EBITDA year-on-year change?
Over the past year, CABA quarterly EBITDA has changed by -$4.98 M (-18.03%)
What is Cabaletta Bio TTM EBITDA?
The current TTM EBITDA of CABA is -$112.92 M
What is the all time high TTM EBITDA for Cabaletta Bio?
Cabaletta Bio all-time high TTM EBITDA is -$3.08 M
What is Cabaletta Bio TTM EBITDA year-on-year change?
Over the past year, CABA TTM EBITDA has changed by -$28.64 M (-33.98%)